Alvotech‘s biosimilar facility was opened in June 2016. The mandate was to create a unique concept for an efficient, flexible, green, biosimilar facility, capable of delivering predefined quantities of biosimilar products, produced by the highest quality standards.
The facility is flexible and allows operation to adapt to market demands with minimal changeover time.
The facility is operating with single use bioreactor technology. We purify, formulate and fill our products in house, for supply of finished and ready to commercialize products to our partners worldwide. Our laboratories are equipped with the latest technologies to allow the testing and release of our products with the best precision available.